143 related articles for article (PubMed ID: 15558944)
1. Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase.
Wang Z; Silverman RB
J Enzyme Inhib Med Chem; 2004 Aug; 19(4):293-301. PubMed ID: 15558944
[TBL] [Abstract][Full Text] [Related]
2. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.
Choi S; Storici P; Schirmer T; Silverman RB
J Am Chem Soc; 2002 Feb; 124(8):1620-4. PubMed ID: 11853435
[TBL] [Abstract][Full Text] [Related]
3. New substrates and inhibitors of gamma-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: design, synthesis, and biological activity.
Yuan H; Silverman RB
Bioorg Med Chem; 2006 Mar; 14(5):1331-8. PubMed ID: 16263300
[TBL] [Abstract][Full Text] [Related]
4. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.
Storici P; De Biase D; Bossa F; Bruno S; Mozzarelli A; Peneff C; Silverman RB; Schirmer T
J Biol Chem; 2004 Jan; 279(1):363-73. PubMed ID: 14534310
[TBL] [Abstract][Full Text] [Related]
5. Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues.
Choi S; Silverman RB
J Med Chem; 2002 Sep; 45(20):4531-9. PubMed ID: 12238932
[TBL] [Abstract][Full Text] [Related]
6. Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators.
Nanavati SM; Silverman RB
J Med Chem; 1989 Nov; 32(11):2413-21. PubMed ID: 2681782
[TBL] [Abstract][Full Text] [Related]
7. A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.
Qiu J; Silverman RB
J Med Chem; 2000 Feb; 43(4):706-20. PubMed ID: 10691696
[TBL] [Abstract][Full Text] [Related]
8. Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.
Lu H; Silverman RB
J Med Chem; 2006 Dec; 49(25):7404-12. PubMed ID: 17149870
[TBL] [Abstract][Full Text] [Related]
9. Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.
Juncosa JI; Groves AP; Xia G; Silverman RB
Bioorg Med Chem; 2013 Feb; 21(4):903-11. PubMed ID: 23306054
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations of apo, holo, and inactivator bound GABA-at reveal the role of active site residues in PLP dependent enzymes.
Gökcan H; Monard G; Sungur Konuklar FA
Proteins; 2016 Jul; 84(7):875-91. PubMed ID: 26800298
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of gamma-aminobutyric acid aminotransferase by (Z)-4-amino-2-fluorobut-2-enoic acid.
Silverman RB; George C
Biochemistry; 1988 May; 27(9):3285-9. PubMed ID: 3390432
[TBL] [Abstract][Full Text] [Related]
12. Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine.
Sulaiman SA; Suliman FE; Barghouthi S
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):297-301. PubMed ID: 14567543
[TBL] [Abstract][Full Text] [Related]
13. Conformationally-restricted vigabatrin analogs as irreversible and reversible inhibitors of gamma-aminobutyric acid aminotransferase.
Pan Y; Calvert K; Silverman RB
Bioorg Med Chem; 2004 Nov; 12(21):5719-25. PubMed ID: 15465348
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase.
Qiu J; Pingsterhaus JM; Silverman RB
J Med Chem; 1999 Nov; 42(22):4725-8. PubMed ID: 10579835
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: a kinetic analysis.
Ricci L; Frosini M; Gaggelli N; Valensin G; Machetti F; Sgaragli G; Valoti M
Biochem Pharmacol; 2006 May; 71(10):1510-9. PubMed ID: 16540097
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of gamma-aminobutyric acid aminotransferase by 3-amino-4-fluorobutanoic acid.
Silverman RB; Roscher CL
Bioorg Med Chem; 1996 Sep; 4(9):1521-35. PubMed ID: 8894109
[TBL] [Abstract][Full Text] [Related]
17. Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.
Yuan H; Silverman RB
Bioorg Med Chem Lett; 2007 Mar; 17(6):1651-4. PubMed ID: 17267220
[TBL] [Abstract][Full Text] [Related]
18. The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.
Silverman RB
J Med Chem; 2012 Jan; 55(2):567-75. PubMed ID: 22168767
[No Abstract] [Full Text] [Related]
19. Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.
Juncosa JI; Takaya K; Le HV; Moschitto MJ; Weerawarna PM; Mascarenhas R; Liu D; Dewey SL; Silverman RB
J Am Chem Soc; 2018 Feb; 140(6):2151-2164. PubMed ID: 29381352
[TBL] [Abstract][Full Text] [Related]
20. Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.
Walters DC; Jansen EEW; Ainslie GR; Salomons GS; Brown MN; Schmidt MA; Roullet JB; Gibson KM
Pharmacol Res Perspect; 2019 Feb; 7(1):e00456. PubMed ID: 30631446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
